東華科技(002140.SZ)被確定為陝煤集團榆林化學相關項目總承包第一中標候選人
格隆匯3月3日丨東華科技(002140.SZ)公佈,2020年3月2日,公司從陝西採購與招標網獲悉,公司被確定為陝煤集團榆林化學有限責任公司煤炭分質利用制化工新材料示範項目一期180萬噸/年乙二醇工程項目乙二醇裝置工程建設PC總承包第一中標候選人。
項目名稱為陝煤集團榆林化學有限責任公司煤炭分質利用制化工新材料示範項目一期180萬噸/年乙二醇工程項目乙二醇裝置工程建設PC總承包;投標報價約13.82億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.